Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors

Clinical trial NCT05024214 · RECRUITING

Trial details

NCT number: NCT05024214
Sponsor: 3D Medicines (Sichuan) Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumors Non-small Cell Lung Cancer Renal Cell Carcinoma Hepatocellular Carcinoma

Start date: 2021-11-15
Primary completion: 2026-12-01
Enrollment: 170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.